8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES

EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): February 13, 2007

PLANAR SYSTEMS, INC.

(Exact name of registrant as specified in its charter)

OREGON	0-23018	93-0835396
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

1195 NW Compton Drive

Beaverton, Oregon 97006

(503) 748-1100

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01. OTHER EVENTS

On February 13, 2007, the business segment financial information attached hereto as Exhibit 99.1 will be made available on the Planar Systems, Inc. website.

Item 9.01. FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits.

99.1 Business segment financial information.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on February 13, 2007.

PLANAR SYSTEMS, INC.
(Registrant)
By	/s/    Scott Hildebrandt
	Scott Hildebrandt
	Vice President and Chief Financial Officer

-2-

EX-99.1

Exhibit 99.1

Planar Systems, Inc.

Historical Business Segment Reporting (in 000's)

Revenue	FYQ105		FYQ205		FYQ305		FYQ405		FY2005		FYQ106		FYQ206		FYQ306		FYQ406		FY2006		FYQ107
Medical	12,110		10,716		9,841		10,298		42,965		11,446		10,618		10,668		11,348		44,080		10,332
Industrial	22,815		23,994		20,599		19,442		86,850		20,276		22,070		20,361		17,318		80,025		16,510
Commercial	28,163		26,386		22,751		24,717		102,017		25,427		20,192		18,336		20,010		83,965		19,230
Control Room & Signage	0		0		0		0		0		0		0		0		4,656		4,656		18,837
Total Revenue	63,088		61,096		53,191		54,457		231,832		57,149		52,880		49,365		53,332		212,726		64,909
Operating Income (Loss)	FYQ105		FYQ205		FYQ305		FYQ405		FY2005		FYQ106		FYQ206		FYQ306		FYQ406		FY2006		FYQ107
Medical	236		92		(148	)	(985	)	(805	)	620		1,147		1,629		1,816		5,212		1,510
Industrial	7,822		7,362		6,521		4,748		26,453		5,133		7,201		5,301		5,123		22,758		4,624
Commercial	(527	)	(859	)	137		782		(467	)	1,453		167		(184	)	(312	)	1,124		(138	)
Control Room & Signage	0		0		0		0		0		0		0		0		703		703		1,055
Corporate	(7,476	)	(11,729	)	(4,922	)	(39,254	)	(63,381	)	(5,222	)	(6,221	)	(4,623	)	(5,208	)	(21,274	)	(10,039	)
Total Operating Income (Loss)	55		(5,134	)	1,588		(34,709	)	(38,200	)	1,984		2,294		2,123		2,122		8,523		(2,988	)

BUSINESS SEGMENTS:

The Company is organized based on various display businesses, primarily specialty displays. Under this organizational structure, the Company operates in four main segments: Medical, Industrial, Commercial, and Control Room and Signage. The Medical segment derives revenue primarily from digital imaging systems for radiology. The Industrial segment derives revenue primarily through the development and marketing of electroluminescent displays (EL), liquid crystal displays and color active matrix liquid crystal displays used in specialty applications. The Commercial segment derives revenue primarily through the marketing of LCD desktop monitors, other touch displays, televisions, screens and projectors that are sold through distributors to end users and includes revenues from the Company’s Home Theater start up business. The Control Room and Signage segment derives revenue primarily through the marketing of scalable video-wall displays and a line of large area flat screen digital signage monitors and software that are sold through distributors and directly to end users.

Effective September 30, 2006 the Company changed the presentation of the Medical and Industrial segments. Certain revenues, which primarily relate to EL products sold for Medical applications, which were previously presented under the Medical segment, have been moved to the Industrial segment. Prior year amounts have been reclassified to conform to the current year segment presentation.

The information provided above is obtained from internal information that is provided to the Company’s chief operating decision-maker for the purpose of corporate management. Operating income (loss) from the business units includes specifically identifiable costs related to research and development, product development, sales and marketing directly associated with each of the business units. Product development expenses are specifically identified by segment. Marketing and sales expenses are specifically identified by segment. Corporate expenses consist of expenses that are not directly associated with a particular segment and include general research expense, general marketing expense, finance and administration expense, human resources expense, information systems expense, restructuring and impairment charges, and acquisition related costs. Stock based compensation has been included as a corporate expense as this information has not been included in the internal information provided to the chief operating decision-maker. Depreciation, interest expense, interest income, other non-operating items and income taxes by segment are not included in the internal segment information provided to the chief operating decision-maker and are therefore not presented separately below. Inter-segment sales are not material and are included in net sales to external customers above.